Actively Recruiting
Genetic Study of Blood Cancers Using Online Surveys and Saliva Samples by Rutgers University
Led by Rutgers, The State University of New Jersey · Updated on 2026-10-01
10000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an online study to better understand how genes influence the risk of blood cancers such as leukemia, lymphoma, and myeloma. This study seeks to identify new genetic variants and study known ones linked to these blood cancers. A diverse group of participants, both with and without blood cancer, will help improve the usefulness of the genetic data. Participants will join by using an online portal to complete health surveys and provide a saliva sample for DNA analysis through a mail-in kit. No in-person visits are required. The study includes both people affected by blood cancers and those who are not. Participants may also choose to share electronic health records, though this is optional. The study runs from 2026 to 2029. During participation, individuals will spend about 20 minutes completing surveys online and sending in their saliva sample by mail. Monthly newsletters help keep participants informed and engaged. The main measurement is identifying genetic risk variants associated with blood cancer over a two-year period, with the goal of advancing understanding that could support future drug development and treatment improvements.
CONDITIONS
Brief Title
Rutgers University Study of the Genetics of Blood Cancers
Research Team
T
Tara Matise, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here